can you take imodium on glp 1 (Loperamide) Prescription How to manage diarrhea related

The starting dose of 0.25 mg once weekly for the first four weeks is primarily intended to improve gastrointestinal tolerability rather than provide maximum therapeutic benefit

Cagrilintidesemaglutide in adults with overweight or obesity and type 2 diabetes (Redefine 2 trial) Summary: This Phase 3a, double-blind, randomized, placebo-controlled trial investigated the efficacy and safety of once-weekly subcutaneous cagrilintidesemaglutide (2.4 mg each) in adults with a BMI of 27 or more and type 2 diabetes

Free fatty acid receptors as mediators and therapeutic targets in liver disease

Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

Dizziness is recognised as a potential side effect of several prescription weight loss medications, particularly those in the glucagon-like peptide-1 (GLP-1) receptor agonist class, such as semaglutide (Wegovy) and liraglutide (Saxenda)